PRAX

MKT CAP:$9B

Praxis Precision Medicines Inc

Market Cap

$9B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$253.25-$33.15 (-11.57%)

Jun 8, 2026

52W High $357.1352W Low $37.70

Company Details

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States....

CEO

—

IPO Date

Oct 16, 2020

Website

praxismedicines.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$327M

EPS (Diluted)

Free Cash Flow

-$283M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 10, 2026

PENDING

Q1 2026

May 7, 2026

FY 2025

Feb 19, 2026

$0-100.0%

Q4 2025

Feb 19, 2026

$0-100.0%

Q3 2025

Nov 5, 2025

$0-100.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee